CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
3 research outputs found
Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma
Author
Callies S
Charles Dumontet
+7Â more
Fadela Bouafia
Franck Morschhauser
Gerrard G
Lisette Sloots
Michael Burgess
Pier Luigi Zinzani
Rubin E H
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes
Author
Bachy Emmanuel
Bouafia Fadela
+14Â more
Bourbon Estelle
Coiffier Bertrand
Ferrant Emmanuelle
Filliatre-Clement Lauriane
Ghergus Dana
Ghesquieres Hervé
Karlin Lionel
Lazareth Anne
Maucort-Boulch Delphine
Safar Violaine
Salles Gilles
Sarkozy Clémentine
Sesques Pierre
Traverse Glehen Alexandra
Publication venue
Wiley
Publication date
02/05/2018
Field of study
No full text
International audienc
HAL-HCL
The superoxide dismutase content in erythrocytes predicts short-term toxicity of high-dose cyclophosphamide
Author
Allalunis-Turner
Benckhuysen
+32Â more
Berrigan
Bertrand Coiffier
Blomeke
Bohnenstengel
Catherine Thieblemont
Charles Dumontet
Daniel Espinouse
DeLeve
Douay
Durken
Fadela Bouafia
Friedman
Gamcsik
Gilles Salles
Gurtoo
Haddad
Jocelyne Drai
Kanekal
Ladner
Lear
Look
Mates
Olivier Hequet
Paglia
Parke
Phillips
Pratt
Schlezinger
Sulkowska
Tamagawa
Tofanetti
Venkatesan
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref